Mary's Medicinals

Mary's Medicinals is a leading developer of cannabinoid-based therapeutic products, recognized for pioneering the use of transdermal technology in the cannabis industry. The company's flagship product is a transdermal patch that offers controlled, long-term delivery of cannabinoids such as THC, CBD, and CBN directly into the bloodstream. Beyond patches, their portfolio includes transdermal gels, topicals, and capsules designed to address indications like chronic pain and inflammation. Mary's Medicinals emphasizes a clinical approach to cannabis, focusing on accurate dosing and high-quality, lab-tested formulations. The company operates as a subsidiary of BellRock Brands, continuing to expand its reach across legal cannabis markets in the United States.